Follow the people · Insider

JK

Jack Kaye

Insider · Director · QURE

Jack Kaye files insider transactions with the SEC as a director of uniQure (QURE). We hold 5 disclosed purchases and sales filed since 22 June 2007, 3 of them in the last 90 days.

  • Files forQURE
  • Disclosed buys and sells5 in all, 3 in the last 90 days
  • Last disclosure2 July 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 27 January 201730 June 2026Director · uniQure (QURE)61 Form 4 lines · source: SEC Form 4
  • Filed 25 June 20192 January 2026Director · Dyadic International (DYAI)30 Form 4 lines · source: SEC Form 4
  • Filed 19 June 200717 June 2015Director · Keryx Biopharmaceuticals (KERX)29 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.